Cairo Journal Club/LinkedIn
Jun 23, 2025, 22:31
Cairo Journal Club and AstraZeneca Launch ADC Academy for Antibody-Drug Conjugate Education
CAIRO Journal Club shared a post on LinkedIn:
“ADC Academy, a new learning platform dedicated to Antibody-Drug Conjugates (ADCs), was developed through a unique collaboration between Cairo Journal Club and AstraZeneca.
Whether you’re a physician, pharmacist, or researcher, ADC Academy is your gateway to staying ahead in the rapidly advancing world of targeted cancer therapeutics.”
Loay Kassem, Assistant Professor of Clinical Oncology at Kasr AlAiny School of Medicine, shared this post, adding:
“Don’t miss this great meeting with top notch experts in the field.
You need to register to the ADC Academy platform to start this educational journey in the hottest topic in modern oncology. “
More posts featuring ADC Academy.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 26, 2025, 14:50
Jun 26, 2025, 14:20
Jun 26, 2025, 13:31